Category: Pharmaceuticals Company Reports
Pharmaceuticals Company Reports market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forWaverley Pharma Inc (WAVE:TSX) compa ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forKnight Therapeutics Inc (GUD:TSE) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAequus Pharmaceuticals Inc (AQ ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAurinia Pharmaceuticals Inc ... Read More
-
Financial Analysis and Multi-Year Benchmarking: AEterna Zentaris Inc (AEZS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: AEterna Zentaris Inc (AEZS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAEterna Zentaris Inc (AEZS:NAS) com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Avant Brands Inc (AVNT:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Avant Brands Inc (AVNT:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAvant Brands Inc (AVNT:TSE) compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Valeo Pharma Inc (VPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Valeo Pharma Inc (VPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forValeo Pharma Inc (VPH:TSE) compared to i ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cipher Pharmaceuticals Inc (CPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cipher Pharmaceuticals Inc (CPH:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCipher Pharmaceuticals Inc (CP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Theralase Technologies Inc (TLT:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Theralase Technologies Inc (TLT:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forTheralase Technologies Inc (TL ... Read More
-
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forHLS Therapeutics Inc (HLS:TSE) compa ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forArbutus Biopharma Corp (ABUS:NAS) ... Read More
-
McKesson Corporation (MCK:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for McKesson Corporation (MCK:NYS) compared to its top competitors and compared to th ... Read More
-
AmerisourceBergen Corporation (ABC:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AmerisourceBergen Corporation (ABC:NYS) compared to its top competitors ... Read More
-
ARS Pharmaceuticals Inc (SPRY:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
ARS Pharmaceuticals Inc (SPRY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for ARS Pharmaceuticals Inc (SPRY:NAS) compared to its top competitors and compar ... Read More
-
Royalty Pharma PLC (RPRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Royalty Pharma PLC (RPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Royalty Pharma PLC (RPRX:NAS) compared to its top competitors and compared to the ... Read More
-
Vertex Inc (VERX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Vertex Inc (VERX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Vertex Inc (VERX:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Cumberland Pharmaceuticals Inc (CPIX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Cumberland Pharmaceuticals Inc (CPIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Cumberland Pharmaceuticals Inc (CPIX:NAS) compared to its top competit ... Read More
-
Intercept Pharmaceuticals Inc (ICPT:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Intercept Pharmaceuticals Inc (ICPT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Intercept Pharmaceuticals Inc (ICPT:NAS) compared to its top competitor ... Read More
-
Ironwood Pharmaceuticals Inc (IRWD:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ironwood Pharmaceuticals Inc (IRWD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ironwood Pharmaceuticals Inc (IRWD:NAS) compared to its top competitors ... Read More
-
AEterna Zentaris Inc (AEZS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AEterna Zentaris Inc (AEZS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AEterna Zentaris Inc (AEZS:NAS) compared to its top competitors and compared to ... Read More
-
AbbVie Inc (ABBV:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AbbVie Inc (ABBV:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AbbVie Inc (ABBV:NYS) compared to its top competitors and compared to the average for all ... Read More
-
Inovio Pharmaceuticals Inc (INO:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Inovio Pharmaceuticals Inc (INO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Inovio Pharmaceuticals Inc (INO:NAS) compared to its top competitors and co ... Read More
-
Ionis Pharmaceuticals Inc (IONS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ionis Pharmaceuticals Inc (IONS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ionis Pharmaceuticals Inc (IONS:NAS) compared to its top competitors and co ... Read More
-
Merck and Co Inc (MRK:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Merck and Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Merck and Co Inc (MRK:NYS) compared to its top competitors and compared to the averag ... Read More
-
Karyopharm Therapeutics Inc (KPTI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Karyopharm Therapeutics Inc (KPTI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Karyopharm Therapeutics Inc (KPTI:NAS) compared to its top competitors an ... Read More
Research Assistance
